Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Change in Cash (2021 - 2025)

Historic Change in Cash for MDxHealth (MDXH) over the last 4 years, with Q3 2025 value amounting to -$795000.0.

  • MDxHealth's Change in Cash fell 10284.72% to -$795000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.3 million, marking a year-over-year decrease of 13948.17%. This contributed to the annual value of $24.4 million for FY2024, which is 25656.74% up from last year.
  • Per MDxHealth's latest filing, its Change in Cash stood at -$795000.0 for Q3 2025, which was down 10284.72% from -$32.9 million recorded in Q2 2025.
  • MDxHealth's 5-year Change in Cash high stood at $33.9 million for Q4 2021, and its period low was -$32.9 million during Q2 2025.
  • In the last 4 years, MDxHealth's Change in Cash had a median value of -$2.5 million in 2024 and averaged $2.3 million.
  • The largest annual percentage gain for MDxHealth's Change in Cash in the last 5 years was 10284.72% (2025), contrasted with its biggest fall of 10284.72% (2025).
  • MDxHealth's Change in Cash (Quarter) stood at $33.9 million in 2021, then plummeted by 122.66% to -$7.7 million in 2022, then soared by 67.9% to -$2.5 million in 2024, then skyrocketed by 67.72% to -$795000.0 in 2025.
  • Its last three reported values are -$795000.0 in Q3 2025, -$32.9 million for Q2 2025, and $18.9 million during Q1 2025.